Studies conducted by Chan et al. [33], Li et al. [34], and Zhang et al. [35] showed that a low pre-treatment serum ALB/ALP ratio independently predicted worse OS, DFS, and RFS in HCC patients receiving curative surgical resection. Here, ALB is linked to hepatocellular carcinoma.